These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7188144)

  • 41. Prophylaxis of migraine: a comparison between naproxen sodium and pizotifen.
    Behan PO; Connelly K
    Headache; 1986 May; 26(5):237-9. PubMed ID: 3522482
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine.
    Havanka-Kanniainen H; Hokkanen E; Myllylä VV
    Cephalalgia; 1987 Mar; 7(1):7-13. PubMed ID: 3555838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of migraine with BC 105 (pizotifen): a double blind trial.
    Arthur GP; Hornabrook RW
    N Z Med J; 1971 Jan; 73(464):5-9. PubMed ID: 4925988
    [No Abstract]   [Full Text] [Related]  

  • 44. Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice.
    Lawrence ER; Hossain M; Littlestone W
    Headache; 1977 Jul; 17(3):109-12. PubMed ID: 330465
    [No Abstract]   [Full Text] [Related]  

  • 45. Severe weight loss after withdrawal of chronic pizotifen treatment.
    Jowett NI
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):137. PubMed ID: 9667582
    [No Abstract]   [Full Text] [Related]  

  • 46. Fulminant hepatitis possibly related to pizotifen therapy.
    Elouni B; Ben Salem C; Zamy M; Poupon R; Bouraoui K; Biour M
    Ann Pharmacother; 2010; 44(7-8):1348-9. PubMed ID: 20571104
    [No Abstract]   [Full Text] [Related]  

  • 47. [Horton's headaches treated with sandomigran (BC-105)].
    Prusiński A; Klimek A
    Wiad Lek; 1973 Feb; 26(4):367-72. PubMed ID: 4688825
    [No Abstract]   [Full Text] [Related]  

  • 48. Placebo, 1-isopropylnoradrenochrome-5-monosemicarbazono and pizotifen in migraine prophylaxis.
    Kangasniemi P
    Headache; 1979 May; 19(4):219-22. PubMed ID: 156165
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis.
    Osterman PO
    Acta Neurol Scand; 1977 Jul; 56(1):17-28. PubMed ID: 327746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-dose pizotifen, 1.5 mg nocte: a new approach in the prophylaxis of migraine.
    Capildeo R; Rose FC
    Headache; 1982 Nov; 22(6):272-5. PubMed ID: 7174305
    [No Abstract]   [Full Text] [Related]  

  • 51. [Zung's test for the quantitative assessment of depression and its confirmation during the testing of a new anti-migraine agent Sandomigran].
    Klapetek J
    Cesk Neurol; 1973 Sep; 36(5):298-303. PubMed ID: 4581588
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients.
    Mazal S; Rachmilewitz EA
    J Neurol Neurosurg Psychiatry; 1980 Dec; 43(12):1137-40. PubMed ID: 7217961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pizotifen in Cushing's disease.
    Kasperlik-Zaluska A; Migdalska B; Wilczynska J; Hartwig W
    Lancet; 1980 Mar; 1(8166):490. PubMed ID: 6102222
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experience with an antaminic drug in the treatment of post-traumatic and vasomotor headaches].
    Brogi L; Zardini GB
    Minerva Med; 1977 Jul; 68(36):2523-30. PubMed ID: 887231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pizotifen in the treatment of underweight patients (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1979 Nov; 118(43-44):1348-53. PubMed ID: 519694
    [No Abstract]   [Full Text] [Related]  

  • 56. Monotherapy or polytherapy in migraine.
    Prusiński A
    Neuroepidemiology; 1987; 6(4):186-9. PubMed ID: 2891054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sandomigrin in migraine therapy].
    Stensrud P; Sjaastad O
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2443-4. PubMed ID: 4657023
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drugs in migraine. I. Preventive treatment].
    Naess K
    Sykepleien; 1981 Jun; 68(11):16-8. PubMed ID: 6116292
    [No Abstract]   [Full Text] [Related]  

  • 59. [Significance of the contribution of pizotifen in correcting appetite disorders and weight insufficiencies].
    Blouza Chachoub S; Achour A; Ben Mansour A; Fareh N; Nagati K; Kallal Z
    Tunis Med; 1989 Mar; 67(3):207-12. PubMed ID: 2756581
    [No Abstract]   [Full Text] [Related]  

  • 60. Antagonism of debrisoquine sulfate by pizotifen (Sandomigran).
    Bailey RR
    N Z Med J; 1976 Jun; 83(566):449. PubMed ID: 1067495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.